DE69909592D1 - Verwendung von thiadiazolo[4,3-a]pyridine derivaten - Google Patents

Verwendung von thiadiazolo[4,3-a]pyridine derivaten

Info

Publication number
DE69909592D1
DE69909592D1 DE69909592A DE69909592A DE69909592D1 DE 69909592 D1 DE69909592 D1 DE 69909592D1 DE 69909592 A DE69909592 A DE 69909592A DE 69909592 A DE69909592 A DE 69909592A DE 69909592 D1 DE69909592 D1 DE 69909592D1
Authority
DE
Germany
Prior art keywords
thiadiazolo
pyridine derivatives
pyridine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69909592A
Other languages
English (en)
Other versions
DE69909592T4 (de
DE69909592T2 (de
Inventor
Walter-Gunar Friebe
Wolfgang Schaumann
Otto-Henning Wilhelms
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Application granted granted Critical
Publication of DE69909592D1 publication Critical patent/DE69909592D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE69909592A 1998-02-17 1999-02-11 Verwendung von thiadiazolo[4,3-a]pyridine derivaten Expired - Fee Related DE69909592D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98102675 1998-02-17
PCT/EP1999/000886 WO1999042089A2 (en) 1998-02-17 1999-02-11 Use of thiadiazolo[4,3-a]pyridine derivatives

Publications (1)

Publication Number Publication Date
DE69909592D1 true DE69909592D1 (de) 2003-08-21

Family

ID=8231426

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69909592A Expired - Fee Related DE69909592D1 (de) 1998-02-17 1999-02-11 Verwendung von thiadiazolo[4,3-a]pyridine derivaten
DE69909592T Expired - Lifetime DE69909592T4 (de) 1998-02-17 1999-02-11 Verwendung von thiadiazolo[4,3-a]pyridine derivaten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69909592T Expired - Lifetime DE69909592T4 (de) 1998-02-17 1999-02-11 Verwendung von thiadiazolo[4,3-a]pyridine derivaten

Country Status (10)

Country Link
US (1) US6326378B1 (de)
EP (1) EP1054669B9 (de)
JP (1) JP3585838B2 (de)
AR (1) AR015518A1 (de)
AU (1) AU2926099A (de)
CA (1) CA2318237A1 (de)
DE (2) DE69909592D1 (de)
ES (1) ES2203086T3 (de)
WO (1) WO1999042089A2 (de)
ZA (1) ZA991233B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1193261A1 (de) * 2000-10-02 2002-04-03 Warner-Lambert Company Thiadiazole und ihre Verwendung als Phosphodiesterase-7 Inhibitoren
EP1348433A1 (de) * 2002-03-28 2003-10-01 Warner-Lambert Company LLC Thiazol-5-yl-imine als PDE7-Inhibitoren
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US7034052B2 (en) * 2003-03-12 2006-04-25 Celgene Corporation 7-Amido-isoindolyl compounds and their pharmaceutical uses
US7564337B2 (en) 2005-03-03 2009-07-21 Littelfuse, Inc. Thermally decoupling fuse holder and assembly

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60246389A (ja) * 1984-05-22 1985-12-06 Nippon Soda Co Ltd ２−スルホニルイミノ−２Ｈ−１，２，４−チアジアゾロ〔２，３−ａ〕ピリジン誘導体及びその製造法
DE4131579A1 (de) * 1991-09-23 1993-03-25 Boehringer Mannheim Gmbh Thiadiazolo(4,3-a)pyridinderivate, verfahren zu ihrer herstellung und diese enthaltenden arzneimittel

Also Published As

Publication number Publication date
JP3585838B2 (ja) 2004-11-04
DE69909592T4 (de) 2005-03-24
AU2926099A (en) 1999-09-06
JP2002503688A (ja) 2002-02-05
EP1054669B1 (de) 2003-07-16
EP1054669A2 (de) 2000-11-29
WO1999042089A3 (en) 1999-10-14
WO1999042089A9 (en) 1999-10-28
CA2318237A1 (en) 1999-08-26
EP1054669B9 (de) 2004-09-15
ES2203086T3 (es) 2004-04-01
AR015518A1 (es) 2001-05-02
US6326378B1 (en) 2001-12-04
WO1999042089A2 (en) 1999-08-26
ZA991233B (en) 1999-08-17
DE69909592T2 (de) 2004-06-03

Similar Documents

Publication Publication Date Title
DK0831829T3 (da) Heterocykliske, ringkondenserede pyrimidinderivater
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
PT950059E (pt) Derivados de sulfona ciclicos
ATE393145T1 (de) Pyridinderivate
IS5722A (is) Pýróló [2,3-dl]pírimídín efnasambönd
DE69804273D1 (de) 5h-Thiazolo[3,2-a]pyrimidinderivate
IS4570A (is) Imidazó[1,2-a]pýridín afleiður
ATE340176T1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
DE69718771T2 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
BR9507666A (pt) Novos derivados de pirimidina
PT1140835E (pt) Derivados da 3,3-biarilpiperidina e 2,2-biarilmorfolina
DE69824872D1 (de) 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridin derivate
DE69909592D1 (de) Verwendung von thiadiazolo[4,3-a]pyridine derivaten
PT931087E (pt) Novos derivados de piranosido
PT963985E (pt) Derivados de di- ou triaza-espiro(4,5)decano
DE69711223T2 (de) Verwendung von cordia dichotoma extrakten
PT796843E (pt) Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol
PT1010699E (pt) Derivados de 3-oxadiazolil-1,6-naftiridina-2(h)-ona substituido em 5
DE69711853T2 (de) Pyridincarboxamid-derivate
DE69710921T2 (de) Heterocyclische substituierte pyrrolidinamid-derivate
PT101876A (pt) Novos derivados de 10,11-di-hidro-10-oxo-5h-dibenzo(b,f)azepina-5-carboxamida
DE29702221U1 (de) Schiebetür
DK146297A (da) Skyderude

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee